Gastrointestinal (GI) Clinical Trial Program

ARGO Study: NSABP C-13
A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients with Stage III Colon Cancer.
A Phase II/III trial of Neoadjuvant FOLFOX, with selective use of combined modality Chemoradiation versus preoperative combined modality Chemoradiation for locally advanced Rectal Cancer patients undergoing low anterior resection with total Mesorectal Excision.
Familial Colorectal Registry
Familial Colorectal Cancer Registry Program.

To access the full protocols, please contact:
Rita McTighe, Oncology Clinical Research Coordinator, at or call (732) 923-6564.